What is Tango Therapeutics Inc?
, a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 4.32B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 5152,056 shares $2.8M | 0 |
| 9-12months | 359,288 shares $727k | 0 |